Detection of complexes which include basement membrane component

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530412, 530413, 530416, 436 64, 436811, 436813, 436820, 435 4, 435 29, C07K 14435, C07K 122, G01N 33483, G01N 33493

Patent

active

055126570

ABSTRACT:
Isolated complexes (which include basement membrane components), antibodies to such complexes or polypeptide constituents thereof, and methods for detecting such complexes or constituents are disclosed. Detection of such complexes in a biological sample by immunological and non-immunological methods allows the diagnosis of a variety of diseases, including cancers, collagen degenerative diseases, and hepatitis. Suitable biological samples include urine, cervical secretions, bronchial aspirates, sputum, saliva, feces, serum, synovial fluid, and cerebrospinal fluid.

REFERENCES:
patent: 4264766 (1981-04-01), Fischer
patent: 4340581 (1982-07-01), Timpl
patent: 4376110 (1983-03-01), David et al.
patent: 4452901 (1984-06-01), Gordon et al.
patent: 4497900 (1985-02-01), Abram et al.
patent: 4565789 (1986-01-01), Liotta et al.
patent: 4609629 (1986-09-01), Timpl
patent: 4628027 (1986-12-01), Gay
patent: 4689220 (1987-08-01), Sturmer et al.
patent: 4829000 (1989-05-01), Kleinman et al.
patent: 4847199 (1989-07-01), Snyder et al.
patent: 5147782 (1992-09-01), Brocks et al.
patent: 5354666 (1994-10-01), Danielson et al.
Albrechtsen et al., "Basement Membrane Changes in Breast Cancer Detected by Immunohistochemical Staining for Laminin," Cancer Res. 41:5076-5081, 1981.
Alitalo et al., "Extracellular Matrix Proteins Characterize Human Tumor Cell Lines," Int. J. Cancer 27:755-761, 1981.
Askenasi, "Urinary hydroxylysine and hydroxylysylglycoside excretions in normal and pathologic states," J. Lab. Clin. Med. 83(4):673-679, 1974.
Babaian et al., "Immune Complexes in Urine and Serum of Patients With Bladder Cancer," J. Urol. 131:463-466, 1984.
Barsky et al., "Loss of Basement Membrane Components by Invasive Tumors but Not by Their Benign Counterparts," Lab. Invest. 49:140-147, 1983.
Bisbee and Kelleher, "A Method for Measuring Hydroxylsine and Glycosylated Hydroxylsines in Urine and Protein Hydrolysates", Clin. Chim. Acta 90:29-36, 1978.
Bowen-Pope et al., "Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by wide spectrum of agents," Proc. Natl. Acad. Sci. USA 81:2396-2400, 1984.
Bowman et al., "Novel Urinary Fragments from Human Basement Membrane Collagen," J. Biol. Chem. 255(19):9484-9489, 1980.
Brocks et al., "Type IV collagen antigens in serum of diabetic rats: a marker for basement membrane collagen biosynthesis," Diabetologia 28:928-932, 1985.
Brocks et al. "Radioimmunoassay of Laminin in Serum and Its Application to Cancer Patients," Clin. Chem. 32(5):787-791, 1986.
Brooks et al., "Human lymphocyte markers defined by antibodies derived from somatic cell hybrids," Clin. Exp. Immunol. 39:477-485, 1980.
Brown et al., "Protein Antigens of Normal and Malignant Human Cells Identified by Immunoprecipitation with Monoclonal Antibodies," J. Biol. Chem. 255(11):4980-4983, 1980.
Burtin et al., "Antigens of the Basement Membrane and the Peritumoral Stroma in Human Colonic Adenocarcinomas: An Immunofluorescence Study," Int. J. Cancer 30:13-20, 1982.
Cederholm et al., "Patients wtih IgA nephropathy have circulating anti-basement membrane antibodies reacting with structures common to collagen I, II, and IV," Proc. Natl. Acad. Sci. USA 83:6151-6155, 1986.
Conn et al., "Basement Membranes in Urothelial Carcinoma," Br. J. Urology, 60:536-542, 1987.
Csako et al., "Similarities and dissimilarities between the binding ability of C1q and collagen," Clin. exp. Immunol. 44:181-190, 1981.
Csako et al., "On the Reactivity of Corneal Collagen and subcomponent C1q of the Complement System with Human Platelets and IgG-Coated Latex Particles," Exp. Eye Res. 36:403-414, 1983.
Dixit, "Isolation, Purification and Characterization of Intact and Pepsin-Derived Fragments of Laminin From Human Placenta," Connective Tissue Research 14:31-40, 1985.
Dresden et al., "Collagenolytic Enzymes in Human Neoplasms," Cancer Research 32:993-996, 1972.
Eeckhout et al., "Agglutination of IgG-Coated Particles By Collagen," FEBS Lett. 107:69-72, 1979.
Fessler et al., "Characterization of the Procollagen IV Cleavage Products by a Specific Tumor Colloagenase," J. Biol. Chem. 259:9783-9789, 1984.
Galfre et al., "Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG," Nature 277:131-133, 1979.
Garbisa et al., "Quantitation of Basement Membrane Collagen Degradation By Living Tumor Cells in Vitro," Cancer Letters, 9:359-366, 1980.
Grant et al., "Elastase Activities of Human Bladder Cancer Cell Lines Derived from High Grade Invasive Tumours," Biochemical and Biophysical Research Communications 162(1):308-315, 1989.
Hewett et al., "Distribution of Collagenase and Tissue Inhibitor of Metalloproteinases (TIMP) in Colorectal Tumours," Int. J. Cancer 49:666-672, 1991.
Hewett et al., "Basement Membrane Collagen-IV Synthesis in Colorectal Tumours," Int. J. Cancer 51:530-536, 1992.
Hewett et al., "Apparent Fusion of Basement Membranes in Colorectal Carcinoma," Int. J. Cancer 50:20-25, 1992.
Huang et al., "Collagenase Activity in Cultures of Rat Prostrate Carcinoma," Biochim. Biophys. Acta 570:149-156, 1979.
Knudsen, "Proteins Transferred to Nitrocellulose for Use as Immunogens," Anal. Biochem. 147:285-288, 1985.
Kobayashi et al., "Circulating Immune Complexes in Patients with Bladder Cancer and Other Malignancies of the Urogenital Tract," Urol. Int. 39:232-235, 1984.
Kohler and Milstein, "Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion," Eur. J. Immunol. 6:511-519, 1976.
Kohler and Milstein, "Continuous cultures of fused cells secreting antibody of predefined specificity," Nature 256:495-497, 1975.
Krane et al. "Urinary Excretion of Hydroxylysine and its Glycosides as an Index of Collagen Degradation," J. Clin. Invest. 59:819-827, 1977.
Linsenmayer et al., "Basement membrane structure assembly: inferences from immunological studies with monoclonal antibodies," Chem. Abst. 101:148327m, 1984.
Liotta et al., "Biochemical Interactions of Tumor Cells With the Basement Membrane," Ann. Rev. Biochem. 55:1037-1057, 1986.
Liotta et al., "Partial Purification and Characterization of a Neutral Protease Which Cleaves Type IV Collagen," Biochemistry 20:100-104, 1981.
Liotta et al., "Degradation of Basement Membrane by Murine Tumor Cells," J. Natl. Cancer Inst. 58:1427-1431, 1977.
Liotta et al., "Metastatic potential correlates with enzymatic degradation of basement membrane collagen," Nature 284:67-68, 1980.
Lipford and Wright, Jr., "Comparative Study of Monoclonal Antibodies TURP-27 and HNK-1: Their Relationship to Neutral Cell Adhesion Molecules and Prostate Tumor-associated Antigens," Cancer Research 51:2296-2301, 1991.
Margulies et al., "Urinary Type IV Collagenase: Elevated Levels Are Associated with Bladder Transitional Cell Carcinoma," Cancer Epidemiology, Biomarkers & Prevention 1:467-474, 1992.
McCabe et al., "A Diagnostic-Prognostic Test for Bladder Cancer Using a Monoclonal Antibody-based Enzyme-Linked Immunoassay for Detection of Urinary Fibrin(ogen) Degradation Products," Cancer Res. 44:5886-5893, 1984.
McCarthy et al., "Localization and Chemical Synthesis of Fibronectin Peptides with Melanoma Adhesion and Heparin Binding Activities," Biochemistry 27:1380-1388, 1988.
Mellon et al., "Increased Concentrations of Basement Membrane Collagen Fragment in Urine of Diabetic Mice," Biochem. Genet. 22:631-639, 1985.
Nagai et al., "Characterization of fibronectin metabolites in normal rat urine," Biochim. Biophys. Acta 967:176-182, 1988.
Nakajima et al., "Basement membrane degradative enzymes as possible markers of tumor metastasis," in Cancer Metastasis: Experimental and Clinical Strategies, Alan R. Liss, Inc. 1986, pp. 113-122.
Nicosia and Bonanno, "Rapid Communication, Inhibition of Angiogenesis In Vitro by Arg-Gly-Asp-Containing Synthetic Peptide," American Journal of Pathology 138(4):829-833, 1991.
Oellerich, "Enzyme-Immunoassay: A Review," J. Clin. Chem. Clin. Biochem. 22:895-904, 1984.
Palm et al., "Alternative Model for the Internal Structure of Laminin," Biochemistry 24:7753-7760, 1985.
Pernice and

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Detection of complexes which include basement membrane component does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Detection of complexes which include basement membrane component, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of complexes which include basement membrane component will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-629668

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.